Association between CTLA-4 Exon-1+49A>G Polymorphism and Primary Biliary Cirrhosis Risk: A Meta-analysis

被引:7
作者
Huang, Qiang [1 ]
Shao, Feng [1 ]
Wang, Cheng [1 ]
Qiu, Lu-jun [1 ]
Hu, Yuan-guo [1 ]
Yu, Ji-hai
机构
[1] Anhui Med Univ, Anhui Prov Hosp, Dept Hepatobiliary Surg, Hefei 230001, Anhui, Peoples R China
关键词
Cytotoxic T-lymphocyte antigen 4; Polymorphism; Primary biliary cirrhosis; Meta-analysis; SINGLE NUCLEOTIDE POLYMORPHISMS; ANTIGEN-4 GENE POLYMORPHISMS; AUTOIMMUNE HEPATITIS; HLA DRW8; SUSCEPTIBILITY; JAPANESE;
D O I
10.1016/j.arcmed.2011.04.004
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background and Aims. CTLA-4 exon-1 +49A>G polymorphisms have been reported to influence the risk for primary biliary cirrhosis in many studies; however, the results still remain controversial and ambiguous. The aim of this study was to determine more precise estimations for the relationship between CTLA-4 exon-1 +49A>G polymorphisms and the risk for primary biliary cirrhosis. Methods. Electronic searches for all publications were conducted on associations between this variant and breast cancer in several databases through November 2010. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to estimate the strength of the association. Eight studies were identified including 2151 cases and 2214 controls. Results. Overall, there were no significant associations between CTLA +49G> A polymorphism and primary biliary cirrhosis risk (codominant model: GA vs. AA OR = 1.190, 95% CI = 0.818-1.732; GG vs. AA OR = 1.153, 95% CI = 0.858-1.550; dominant model: OR = 1.181,95% CI = 0.873-1.599; and recessive model: OR = 1.148; 95% CI = 0.903-1.459). In the subgroup analysis by ethnicity, a significantly increased risk was found for Asians (GG vs. AA OR = 1.873; 95% CI = 1.202-2.921) and recessive model (OR = 1.758; 95% CI = 1.271-2.433). In the stratified analysis by control sources, significant association were observed in population-based studies (GA vs. AA OR = 1.432; 95% CI = 1.078-1.902). Conclusions. This meta-analysis suggests that the CTLA-4 +49G> A polymorphism may be a risk factor for primary biliary cirrhosis in Asians. (C) 2011 IMSS. Published by Elsevier Inc.
引用
收藏
页码:235 / 238
页数:4
相关论文
共 27 条
[1]   CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis [J].
Agarwal, K ;
Jones, DEJ ;
Daly, AK ;
James, OFW ;
Vaidya, B ;
Pearce, S ;
Bassendine, MF .
JOURNAL OF HEPATOLOGY, 2000, 32 (04) :538-541
[2]   Analysis of major histocompatibility complex and CTLA-4 alleles in Brazilian patients with primary biliary cirrhosis [J].
Bittencourt, PL ;
Palácios, SA ;
Farias, AQ ;
Abrantes-Lemos, CP ;
Cançado, ELR ;
Carrilho, FJ ;
Laudanna, AA ;
Kalil, J ;
Goldberg, AC .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (09) :1061-1066
[3]   THE COMBINATION OF ESTIMATES FROM DIFFERENT EXPERIMENTS [J].
COCHRAN, WG .
BIOMETRICS, 1954, 10 (01) :101-129
[4]   HUMAN IG SUPERFAMILY CTLA-4 GENE - CHROMOSOMAL LOCALIZATION AND IDENTITY OF PROTEIN-SEQUENCE BETWEEN MURINE AND HUMAN CTLA-4 CYTOPLASMIC DOMAINS [J].
DARIAVACH, P ;
MATTEI, MG ;
GOLSTEIN, P ;
LEFRANC, MP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (12) :1901-1905
[5]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[6]   Cytotoxic T-lymphocyte-associated antigen-4 single nucleotide polymorphisms and haplotypes in primary biliary cirrhosis [J].
Donaldson, Peter ;
Veeramani, Sivakumar ;
Baragiotta, Anna ;
Floreani, Annarosa ;
Venturi, Carla ;
Pearce, Simon ;
Wilson, Valerie ;
Jones, David ;
James, Oliver ;
Taylor, John ;
Newton, Julia ;
Bassendine, Margaret .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (06) :755-760
[7]  
Fan LY, 2004, WORLD J GASTROENTERO, V10, P3056
[8]   The causes of primary biliary cirrhosis: Convenient and inconvenient truths [J].
Gershwin, M. Eric ;
Mackay, Ian R. .
HEPATOLOGY, 2008, 47 (02) :737-745
[9]   Risk factors and comorbidities in primary biliary cirrhosis: A controlled interview-based study of 1032 patients [J].
Gershwin, ME ;
Selmi, C ;
Worman, HJ ;
Gold, EB ;
Watnik, M ;
Utts, J ;
Lindor, KD ;
Kaplan, MM ;
Vierling, JM .
HEPATOLOGY, 2005, 42 (05) :1194-1202
[10]  
GREGORY WL, 1993, Q J MED, V86, P393